Written by Klarity Editorial Team
Published: May 31, 2026

If you’re a psychiatrist or PMHNP considering telehealth work, one question keeps coming up: Can I actually prescribe anxiety medications remotely — including controlled substances like benzodiazepines?
Short answer: Yes. As of 2026, federal rules still allow you to prescribe controlled anxiety medications via telehealth without requiring an initial in-person visit. This flexibility has been extended through December 2026, giving providers continued access to the telemedicine prescribing authority that’s kept millions of anxiety patients in care since COVID.
But here’s the catch — state rules vary wildly, especially if you’re a PMHNP. Your prescribing authority for anxiety meds depends on where you’re licensed, your provider type, and whether you have the right collaborative agreements in place (if your state requires them).
Let’s break down what you can actually do, where the regulatory landmines are, and how joining a telehealth platform like Klarity removes the guesswork.
Historically, the Ryan Haight Act required at least one in-person exam before prescribing Schedule II-V controlled substances. That’s been suspended since March 2020, and the DEA has extended these telehealth flexibilities through the end of 2026.
What this means for you:
In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these rules. The DEA is working on permanent regulations expected late 2026 — likely requiring some form of special telemedicine registration — but for now, the temporary rules remain in effect.
Important: Even with federal allowance, you must:
Federal law sets the floor, but state telehealth and scope-of-practice laws determine what you can actually do. Here’s what matters most in our priority states:
Psychiatrists (MD/DO): Full authority to prescribe any anxiety medication via telehealth. No state restrictions beyond federal rules.
PMHNPs: California is mid-transition. Until 2023, NPs needed physician supervision and standardized procedures to prescribe anything. AB 890 changed this:
If you’re an established PMHNP in California, you may finally be able to open your own telehealth practice without a supervising physician. New grads still need to work through the 103 pathway first.
Psychiatrists: Full independent authority. Can prescribe any anxiety medication via telehealth as long as you establish a proper patient-provider relationship (video exam satisfies this).
PMHNPs: Texas remains one of the most restrictive states. You must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. The physician doesn’t co-sign every script, but they supervise with periodic chart reviews.
Major limitation: Texas NPs cannot prescribe Schedule II controlled substances in outpatient settings except in hospitals (24+ hour admissions), ERs, or hospice care. This means if your anxiety patient needs a stimulant for comorbid ADHD, you can’t prescribe it independently as an NP. Benzodiazepines (Schedule IV) are fine under your delegation agreement.
Telehealth caveat: Texas bans telemedicine treatment of chronic pain with controlled substances — but anxiety treatment doesn’t fall under this prohibition.
Psychiatrists: Can prescribe any anxiety medication via telehealth. Florida specifically allows teleprescribing of Schedule II controlled substances when treating psychiatric disorders (even though Schedule II is otherwise banned via telehealth for most uses).
PMHNPs: Florida requires a written protocol with a supervising physician. You can prescribe controlled substances if your protocol permits it, with these caveats:
Out-of-state caveat: Florida offers a ‘Telehealth Provider Registration’ for out-of-state prescribers, but registrants cannot prescribe controlled substances in Florida. You need a full Florida license for that.
Both Psychiatrists and PMHNPs: New York is now a full practice authority state for NPs. As of April 2022, PMHNPs can practice and prescribe completely independently — no written agreements, no mandatory collaboration.
For anxiety treatment, a PMHNP in New York has essentially the same prescribing authority as a psychiatrist. The only difference is reimbursement (NPs get ~85% of physician rates under Medicare) and perhaps patient perception.
Telehealth: No state restrictions on virtual prescribing. You must check the iSTOP PDMP before every controlled substance prescription (New York has one of the strictest PDMP mandates in the country).
Psychiatrists: Full independent authority for telehealth prescribing.
PMHNPs: Pennsylvania requires a Collaborative Agreement with a physician for your entire career (no pathway to independence yet, despite multiple legislative attempts). The physician must review a percentage of your charts and co-sign Schedule II prescriptions within 24 hours.
For anxiety management, you can prescribe benzodiazepines and SSRIs under your collaboration, but if you need to prescribe a Schedule II medication (like Adderall for comorbid ADHD), your supervising physician must be directly involved.
Psychiatrists: Full authority, no restrictions.
PMHNPs: Illinois has a pathway to full practice authority after you complete 4,000 clinical hours + 250 CE hours post-graduation. Once you meet those milestones, you can practice independently.
Controlled substance caveat: Even with full practice authority, Illinois NPs need a one-time physician consultation agreement for prescribing benzodiazepines or Schedule II drugs — essentially a physician signs off that you’re authorized to prescribe these categories. After that, you can prescribe them independently (though you maintain the relationship for consultation purposes).
New PMHNPs in Illinois start with required physician collaboration until they hit those hour requirements.
The clinical training difference is significant:
But for routine anxiety medication management — starting an SSRI, adjusting doses, prescribing a short-term benzodiazepine for panic attacks — PMHNPs are extremely effective. Studies show comparable outcomes for common mental health conditions.
The authority gap is entirely state-dependent:
For patients: There’s often no practical difference in care quality between a PMHNP and psychiatrist for straightforward anxiety cases. The difference shows up in complex cases requiring multiple medication trials, unusual comorbidities, or when a patient specifically needs Schedule II medications that some states restrict for NPs.
For providers: If you’re a PMHNP, your earning potential and autonomy depend heavily on your state. Full practice authority states offer more flexibility and often higher compensation since you’re not splitting revenue with a collaborating physician or paying supervision fees.
Here’s the economic reality of psychiatric medication management in 2026:
Medicare rates (national averages):
Medicaid rates: Roughly 50-60% of Medicare
Private insurance: Typically 100-150% of Medicare, depending on contracts
Telehealth parity: Most states now require insurers to pay the same rate for telehealth as in-person for mental health services. This has been a game-changer — you can see patients from your home office and get paid the same as if they came to a clinic.
PMHNP reimbursement: Medicare and most insurers pay NPs at 85% of the physician rate. Some practices try to use ‘incident to’ billing to get 100%, but this rarely works in psychiatry due to the direct provider-patient nature of med management.
Volume matters: A psychiatrist doing 4-5 medication checks per hour at $95-135 each can generate $400-600+/hour in gross billings. After overhead and practice costs, net income for a busy telepsychiatry practice can easily hit $200-300K+ working reasonable hours.
The low overhead of telehealth makes these numbers work — no office lease, minimal staff, and platforms handle billing/credentialing for you.
Here’s what nobody tells you about building your own telehealth practice:
The real cost of patient acquisition:
Most ‘marketing gurus’ will tell you can acquire psychiatric patients for ‘$30-50 per lead’ through Google Ads or SEO. That’s fantasy math.
Reality check on DIY marketing costs:
Total monthly marketing spend for a solo practice: Easily $3,000-5,000+ with no guarantee you’ll get enough qualified patients to break even.
Hidden costs nobody mentions:
Why platforms like Klarity make sense economically:
Instead of gambling $5,000/month on marketing with uncertain results, Klarity uses a pay-per-appointment model (similar to Zocdoc but for psychiatric care specifically).
Here’s what you actually get:
The ROI difference:
DIY approach: Spend $4,000 in marketing → hope you get 10-15 new patients → maybe 5 become regular patients → gross revenue ~$2,000-3,000 first month → net loss
Platform approach: List your availability → qualified patients book → you pay a standard fee per new patient lead (competitive with Zocdoc’s booking fees) → guaranteed ROI from day one because you only pay when patients actually show up
For most providers, especially those starting out or scaling up, the platform model removes all the risk. You’re not betting on whether your marketing will work — you’re plugging into an existing patient flow.
Can psychiatrists prescribe Xanax via telehealth?
Yes. Under current federal rules (extended through December 2026), psychiatrists can prescribe benzodiazepines like alprazolam (Xanax) via video visits without a prior in-person encounter. You must check your state PDMP and follow standard controlled substance prescribing guidelines.
Can PMHNPs prescribe anxiety medications independently?
Depends on your state. In full practice authority states (New York, Arizona, Oregon, etc.), yes — you can prescribe any anxiety medication including controlled substances independently. In restricted states (Texas, Pennsylvania, Florida), you need a physician collaborative agreement and may face additional limits on Schedule II prescriptions.
Do I need a DEA license to prescribe anxiety meds via telehealth?
Yes, if you’re prescribing controlled substances like benzodiazepines. You need both a DEA registration in the state where you’re licensed and potentially state-specific controlled substance authority (varies by state). Non-controlled anxiety medications (SSRIs, SNRIs, buspirone) don’t require DEA registration.
What happens when the federal telehealth prescribing flexibility ends?
The current extension runs through December 2026. The DEA is expected to issue permanent regulations by late 2026, likely requiring a special telemedicine prescribing registration. Most experts expect the new rules will preserve telehealth prescribing in some form, given that 7+ million patients now rely on it.
Can I prescribe anxiety meds to patients in other states via telehealth?
Only if you hold a valid medical license in the state where the patient is located during the consultation. Some states participate in the Interstate Medical Licensure Compact (IMLC) which streamlines multi-state licensing for physicians. For NPs, multi-state practice requires separate state licenses (some states recognize the Nurse Licensure Compact for basic RN licenses, but prescribing authority is governed by individual state NP laws).
Are telehealth appointments reimbursed the same as in-person for psychiatry?
In most states, yes. Federal Medicare and many state laws require telehealth parity for mental health services — meaning insurers must pay the same rate whether the visit is virtual or in-person. This has been extended through at least 2026 for Medicare, though the periodic in-person requirement (once every 6 months) may eventually be enforced for Medicare tele-mental health.
What if my state requires physician collaboration and I can’t find a collaborating physician?
This is a common barrier for PMHNPs in restricted states. Options include: (1) joining a large telehealth platform that arranges physician collaborations as part of their provider model, (2) networking through state NP associations to find collaborative psychiatrists, or (3) paying a physician collaboration service (typically $100-300/month). Some PMHNPs also pursue licensure in nearby full practice authority states to expand their options.
If you’re a psychiatrist: You have full authority to practice telepsychiatry and prescribe any anxiety medication in any state where you’re licensed. The barriers are minimal — get licensed in the states you want to serve, register for DEA, and you’re ready to go.
If you’re a PMHNP: Your authority depends entirely on state law. In progressive states like New York, you’re on equal footing with psychiatrists. In restrictive states, you’ll need physician collaboration and may face limits on controlled substances. Consider whether multi-state licensure in FPA states makes sense for your career.
For both: The economics of DIY practice building are daunting. Marketing spend is high, patient acquisition is uncertain, and you’re burning months of time and money before seeing results. Platforms like Klarity offer a faster, lower-risk path to a full patient panel — you pay only when qualified patients actually book with you, and all the infrastructure (credentialing, billing, telehealth platform) is handled for you.
The demand for anxiety treatment is massive and growing. Psychiatrist shortages mean patients in states like Texas (1 psychiatrist per ~9,000 residents), Florida (1:8,577), and Illinois (1:5,849) are waiting weeks or months for care. Telehealth can bridge that gap — if you understand the rules and have a sustainable way to reach patients.
Ready to start seeing anxiety patients without the marketing gamble? Klarity connects prescribers with pre-qualified patients, handles all the administrative overhead, and lets you focus on what you do best — providing care. You set your schedule, we fill your calendar. Join Klarity’s provider network to learn more.
HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (Official .gov source, published Jan 2, 2026) – Federal government confirmation of extended telehealth prescribing authority for controlled substances through December 2026.
Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (Official state .gov, 2024 Statutes effective 2024-25) – State law defining PMHNP scope of practice and telehealth prescribing rules in Florida, including 7-day limit exceptions for psychiatric NPs.
California Board of Registered Nursing – AB 890 Implementation FAQs (Official state board source, updated 2024) – State regulatory guidance on new 103/104 NP independent practice categories and transition timeline through 2026.
NPNY announcement – ‘NP Modernization Act Passes in NY’ (Professional association blog, published April 9, 2022) – Documents New York’s shift to full practice authority for nurse practitioners eliminating collaborative agreement requirements.
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (Industry professional blog, 2025 with 2026 rates) – Aggregates CMS Medicare reimbursement data for psychiatric billing codes including 90792, 99213, 99214, and psychotherapy add-ons.
Find the right provider for your needs — select your state to find expert care near you.